EW Financial Facts
Basic (in shares): 213.2MNet sales: 739.4M
See Full Income Statement
Accounts payable and accrued liabilities: 532.8M
Other intangible assets, net (Note 5): 207M
See Full Balance Sheet
Edwards Lifesciences Corp. (EW) Earnings
|
Expand Research on EW
| Next EPS Date | 7/24/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +5.5% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +3.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/29/26  |
Q126 | N/A | $0.73 | N/A | N/A | $1.6B | = | N/A | N/A | ||
| 2/10/26 | Q425 | $0.58 | $0.62 | -$0.04 | $1.57B | $1.55B | = |  | | Details | |
| 10/30/25 | Q325 | $0.67 | $0.59 | +$0.08 | $1.55B | $1.5B | = | | | Details | |
| 7/24/25 | Q225 | $0.67 | $0.62 | +$0.05 | $1.53B | $1.49B | = | | | Details | |
| 4/23/25 | Q125 | $0.64 | $0.60 | +$0.04 | $1.41B | $1.4B | = | | | Details | |
| 2/11/25 | Q424 | $0.59 | $0.55 | +$0.04 | $1.39B | $1.36B | = | | | Details | |
| 10/24/24 | Q324 | $0.67 | $0.66 | +$0.01 | $1.35B | $1.57B | = | | | Details | |
| 7/24/24 | Q224 | $0.70 | $0.69 | +$0.01 | $1.63B | $1.65B | = | | | Details |
